| Primary |
| Blood Pressure Management |
22.2% |
| Pain |
22.2% |
| Product Used For Unknown Indication |
22.2% |
| Spinal Anaesthesia |
22.2% |
| Caesarean Section |
11.1% |
|
|
| Secondary |
| Anaesthesia |
21.8% |
| Product Used For Unknown Indication |
19.1% |
| General Anaesthesia |
8.0% |
| Sedation |
6.8% |
| Induction Of Anaesthesia |
5.7% |
| Drug Use For Unknown Indication |
5.2% |
| Supplementation Therapy |
4.8% |
| Drug Exposure Via Mother |
4.1% |
| Pain |
4.1% |
| Pancreatitis |
3.9% |
| Maternal Exposure Timing Unspecified |
2.3% |
| Hypertension |
2.1% |
| Maintenance Of Anaesthesia |
2.0% |
| Foetal Exposure During Pregnancy |
2.0% |
| Prophylaxis |
1.8% |
| Thrombosis Prophylaxis |
1.5% |
| Premedication |
1.3% |
| Alcohol Withdrawal Syndrome |
1.2% |
| Antibiotic Prophylaxis |
1.2% |
| Epidural Anaesthesia |
1.2% |
|
| Cognitive Disorder |
15.9% |
| Rhabdomyolysis |
10.1% |
| Tachycardia |
8.5% |
| Anaphylactic Shock |
7.9% |
| Dementia Alzheimer's Type |
6.9% |
| Premature Baby |
6.9% |
| Rash |
6.3% |
| Shock |
6.3% |
| Foetal Growth Restriction |
4.2% |
| Hepatocellular Injury |
3.7% |
| Toxic Epidermal Necrolysis |
3.7% |
| Spinal Anaesthesia |
3.2% |
| Haemodynamic Instability |
2.6% |
| Hypersensitivity |
2.6% |
| Myocardial Infarction |
2.6% |
| Viith Nerve Paralysis |
2.1% |
| Cardiac Arrest |
1.6% |
| Haemorrhage |
1.6% |
| Hyperthermia Malignant |
1.6% |
| Hypotension |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.2% |
| General Anaesthesia |
8.1% |
| Drug Use For Unknown Indication |
6.9% |
| Anaesthesia |
6.7% |
| Prophylaxis |
6.7% |
| Sedation |
5.9% |
| Induction Of Anaesthesia |
5.4% |
| Diverticular Perforation |
3.6% |
| Pain |
3.3% |
| Coronary Artery Bypass |
2.8% |
| Pneumonia |
2.7% |
| Analgesic Therapy |
2.1% |
| Postoperative Analgesia |
2.1% |
| Hypertension |
1.9% |
| Maintenance Of Anaesthesia |
1.9% |
| Status Epilepticus |
1.9% |
| Sepsis |
1.6% |
| Epilepsy |
1.5% |
| Muscle Spasticity |
1.4% |
| Antibiotic Therapy |
1.3% |
|
| Portal Vein Thrombosis |
9.0% |
| Sepsis |
7.9% |
| Thrombocytopenia |
7.9% |
| Drug Interaction |
6.7% |
| Stress |
6.7% |
| Fear |
5.6% |
| Injury |
5.6% |
| Multi-organ Failure |
5.6% |
| Renal Failure Acute |
5.6% |
| Death |
4.5% |
| Hyperlipasaemia |
4.5% |
| Agranulocytosis |
3.4% |
| Drug Withdrawal Syndrome |
3.4% |
| Incorrect Drug Administration Rate |
3.4% |
| Pain |
3.4% |
| Postoperative Ileus |
3.4% |
| Pulmonary Congestion |
3.4% |
| Renal Impairment |
3.4% |
| Shock |
3.4% |
| Tachycardia |
3.4% |
|
| Interacting |
| Cancer Pain |
83.3% |
| Renal Cancer Metastatic |
16.7% |
|
|
